Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48688 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.449 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44715 | 18 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.40036 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.40192 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.49858 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.47584 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43194 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.42093 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.44322 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.70336 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.41958 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.44732 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.44789 | 19 |